Stockreport

ORIC Pharmaceuticals Presents Preclinical Data on CD73 Inhibitor at the American Association for Cancer Research (AACR) Virtual Annual Meeting

Oric Pharmaceuticals, Inc.  (ORIC) 
PDF Orally bioavailable small molecule CD73 inhibitors reverse immunosuppression by blocking adenosine production Internal research program led to discovery of clinical c [Read more]